EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bionano Genomics's Enterprise Value is $26.17 Mil.
Bionano Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-227.31 Mil. Therefore, Bionano Genomics's EV-to-EBIT for today is -0.12.
The historical rank and industry rank for Bionano Genomics's EV-to-EBIT or its related term are showing as below:
BNGO'
s EV-to-EBIT Range Over the Past 10 Years
Min: -66.82 Med: -1.82 Max: 1.24
Current: -0.12
During the past 8 years, the highest EV-to-EBIT of Bionano Genomics was 1.24. The lowest was -66.82. And the median was -1.82.
BNGO's EV-to-EBIT is ranked worse than 100% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 19.86
vs BNGO: -0.12
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bionano Genomics's Enterprise Value for the quarter that ended in Dec. 2023 was $64.00 Mil.
Bionano Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-227.31 Mil. Bionano Genomics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -355.20%.
Bionano Genomics EV-to-EBIT Historical Data
The historical data trend for Bionano Genomics's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Bionano Genomics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionano Genomics EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Bionano Genomics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Bionano Genomics's EV-to-EBIT falls into.
Bionano Genomics EV-to-EBIT Calculation
Bionano Genomics's EV-to-EBIT for today is calculated as:
Bionano Genomics's current Enterprise Value is $26.17 Mil.
Bionano Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-227.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Bionano Genomics's Enterprise Value for the quarter that ended in Dec. 2023 was $64.00 Mil.
Bionano Genomics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-227.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionano Genomics EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Bionano Genomics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Bionano Genomics (Bionano Genomics) Business Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BNGO has been successfully added to your 